Page 181 - pharma 1 theoretical updated MNU_Neat
P. 181

Clinical pharmacy 2024/2025                            Level 3 Pharm D                             Pharmacology 1 (PO 502)
                                                  Eicosanoids


          Eicosanoids, from the Greek eikosi “twenty” are formed from precursor essential fatty
            acids that contain 20 carbons and 3, 4, or 5 double bonds.

                         Membrane lipids supply the substrate for the synthesis of eicosanoids and
                          platelet-activating factor (PAF).
           Types
                         Arachidonic  acid  (AA)  metabolites,  including  prostaglandins  (PGs),
                          prostacyclin (PGI2), thromboxane A (TxA2), leukotrienes (LTs).
                         Eicosanoids  and  PAF  lipids  function  as  signaling  molecules  in  many

                          biological processes, including the regulation of vascular tone, renal function,
         Function
                          hemostasis, GI mucosal integrity, and stem cell function.

                         They are also important mediators of innate immunity and inflammation.
                       ✓  Eicosanoids are not stored but are produced by most cells when a variety of
                           physical,  chemical,  and  hormonal  stimuli  activate  phospholipase A2  that

                           makes arachidonate available.
                       ✓  Arachidonic acid is the primary precursor of the prostaglandins and related
                           compounds, and it is present as a component of the phospholipids of cell

                           membranes.
                       ✓  Free arachidonic acid is released from tissue phospholipids by the action of
                           phospholipase A2 via a process controlled by hormones and other stimuli.
                       ✓  Corticosteroids  can  block  the  action  of  phospholipase  A2,  so  has  anti-

                           inflammatory effect
                       ✓  There  are  two  major  pathways  in  the  synthesis  of  eicosanoids  from
                           arachidonic acid, the cyclooxygenase and the lipoxygenase pathways.
         Synthesis                        ✓  Eicosanoids  with  ring  structures  (that  is,  prostaglandins,
                       Cyclooxygenase         thromboxane,  and  prostacyclin)  are  synthesized  via  the
                           pathway
                                              cyclooxygenase pathway.

                                                 COX-1                                         COX-2
                       •  It is responsible for the physiologic production         •  It causes the elevated

                           PGs and thromboxane.                                        production of PGs
                       •  It is a constitutive enzyme that regulates normal            that occurs in sites of
                           cellular processes, such as gastric protection,             chronic disease and

                           vascular homeostasis, platelet aggregation, and             inflammation.
                           reproductive and kidney functions.
                        Lipoxygenase  ✓  Several lipoxygenases can act on arachidonic acid to form

                           pathway            leukotrienes.
        NB: Several classes of drugs, most notably NSAIDs, including aspirin, owe their principal
        therapeutic effects—relief of inflammatory pain and antipyresis—to blockade of PG

        formation.



                                                                                                     | P a g e  165
   176   177   178   179   180   181   182   183   184   185   186